medigraphic.com
Órgano Oficial del Instituto de Ciencias de la Salud, Hospital Escuela y Facultad de Medicina-Xalapa

2017, Number 2

<< Back Next >>

Rev Med UV 2017; 17 (2)

Metabolic syndrome, a public health problem with different definitions and criteria

Castillo HJL, Cuevas GMJ, Almar GM, Romero HEY

Language: Spanish
References: 55
Page: 7-24
PDF size: 298.38 Kb.


ABSTRACT

Metabolic Syndrome (MS) is a pathology that affects individuals from all countries, from all continents and from all economic strata. Overweight and obesity are strongly associated with the MS and generate direct stratospheric costs for people who suffer from it, for society and for the government due to its impact on adjusted life years of the disability and the costs of their care and treatment. Objective: To characterize the SM as a public health problem associated with central obesity, metabolic nature, that requires agreements regarding its definition in order to make comparisons on prevalence in local and international areas. Materials and methods: Considering the criteria, definition and history was searched in the database, indexed journals and specialized sites. Results. The preliminary search for a total of 189 potentially eligible articles, of which only include a systematic review and 19 articles. Conclusions, The MS has multiple origins but obesity and sedentary lifestyle combined with an unbalanced diet - in addition to genetic factors - clearly interact to occur, so it constitutes a serious public health problem given their criteria of magnitude, transcendence and vulnerability that in order to make comparisons at the national and international levels requires agreements for the adoption of a definition and diagnostic criteria.


REFERENCES

  1. Aguilera Eugia, R., Vergara Miranda C., Quezada Donoso R., Sepúlveda Silva M., Coccio N., Cortés P., Delarse C. y Flores C. (2015). Ejercicio intervalado de alta intensidad como terapia para disminuir los factores de riesgo cardiovascular en personas con síndrome metabólico. Nutr. Hosp. 1 32(6), 2460-71. Recuperado de: https://medes.com/publication/106290

  2. Alberti G, Zimmet, P., Shaw J. (2006) Metabolic Syndrome: a New World-wide Definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 23,469-80. Recuperado de: https://www.ncbi.nlm.nih.gov/pubmed/16681555

  3. Alberti KG, Zimmet, P., Shaw, J., IDF Epidemiology Task Force Consensus Group. (2005). The Metabolic Syndrome: a new Worldwide Definition. Lancet, 366 (9491), 1059-62. Pub Med, PMID: 16182882. Recuperado de: http://www.thelancet.com/journals/lancet/article/PIIS0140- 6736(05)67402-8/fulltext

  4. Alberti KG, Zimmet, P. (1998). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a WHO Consultation. Diabet Med., 15(7), 539-53. Recuperado de: https://www.ncbi.nlm.nih.gov/ pubmed/9686693

  5. Allison DB, Kaprio J., Korkeila M., Koskenvuo M., Neale M., Hayakawa, K. (1996). The Heritability of Body Mass Index among an International Sample of Monozygotic Twins Reared Apart. International Journal of Obesity and related Metabolic Disorders, 20(6), 501-6. Recuperado de: https://www.ncbi. nlm.nih.gov/pubmed/8782724

  6. Asociación Latinoamericana de Diabetes. (2013) Guías ALAD sobre el diagnóstico, control y tratamiento de la Diabetes Mellitus tipo 2 con medicina basada en la evidencia. Rev. ALAD. Recuperado de: https://issuu.com/alad-diabetes/docs/guias_alad_2013

  7. Balkau, B., Charles, M.A. (1999). Comment on the Provisional Report from the WHO Consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med.16 (5), 442-3. Recuperado de: https://www.unboundmedicine.com/medline/citation/10342346/Comment_on_the_provisional_ report_from_the_WHO_consultation__European_Group_for_the_Study_of_Insulin_Resistance__EGIR_

  8. Barrera MP, Pinilla A.E., Cortés E., Mora G., Rodríguez, M.N. (2008). Síndrome metabólico: una mirada interdisciplinaria. Rev. Colomb. Cardiol., 15 (3), 111-26. Recuperado de: http://www.scielo. org.co/pdf/rcca/v15n3/v15n3a4.pdf

  9. Bellis, A., Trimarco, B. (2013). Pharmacological Approach to Cardiovascular Risk in Metabolic Syndrome. J. Cardiovasc. Med. 14(6), 403-9. Recuperado de: https://www.ncbi.nlm.nih.gov/ pubmed/23337396

  10. Carrillo Esper, R., Sanchez Zuñiga, M.J., Elizondo Argueta, S. (2006). Síndrome Metabólico. Rev. Fac. Med. UNAM, 49(3). Recuperado de: http://www.medigraphic.com/pdfs/facmed/un-2006/ un063e.pdf

  11. Castillo Hernández, J.l., Romero Hernández, E.Y., Galiana M.A., Cuevas González, M.J. (2015). Síndrome Metabólico e índice general de acondicionamiento físico en estudiantes de la Facultad de Nutrición Xalapa de la Universidad Veracruzana. Rev. Med. de la UV. 15(2), 35-50. Recuperado de: https://www.uv.mx/rm/num_anteriores/revmedica_vol15_num2/articulos/sindrome.pdf

  12. Comuzzie, A.G., Willimas, J.T., Blangero, M.J. (2014) Searching for Genes Underlying Normal Variation in Human Adiposity. J. of Mol. Med. (79), 57-50. Recuperado de : https://www.ncbi.nlm.nih. gov/pubmed/11327104

  13. Da Silva, A.R., De Sousa, L.S., Rocha, T. de S, Cortes RM, Macedo, LG, De Almeida, PC. (2014). Prevalencia de componentes metabólicos en universitarios. Rev. Lat. Am. Enfermagen, 22(6),1041-7. Recuperado de http://www.scielo.br/pdf/rlae/v22n6/es_0104-1169-rlae-22-06-01041.pdf

  14. Gimeno, JA., Lou Arnal, LM., Molinero Herguedas, E., Boned Julián, B., Portilla Córdoba, DP. (2004). Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2. Rev. Esp. Cardiol.57(6), 507-513. Recuperado de: http://www.revespcardiol.org/sites/default/files/ elsevier/pdf/25/25v57n06a130629 16pdf001.pdf

  15. Gómez Pérez F., Ríos T, JM, Aguilar Salinas, CA, Lerman, GI., Rull JA. (2005) Posición de la SMNE sobre el manejo del síndrome metabólico. Revista de endocrinología y nutrición, 13 (1), 9-23. Recuperado de: http://new.medigraphic.com/cgi-bin/resumen.cgi?IDARTICULO=1821

  16. González Sandoval, C.E., Diaz Burke, Y., Mendizábal Ruiz, AP., Medina Díaz, E., Morales, JA. (2014). Prevalencia de obesidad y perfil lipídico alterado en jóvenes universitarios. Nutr. Hosp. 1; 29(2),315- 21. Recuperado de: http://scielo.isciii.es/pdf/nh/v29n2/10originalobesidad05.pdf

  17. Guerrero Montoya, L R., León Salazar, A R., (2010). Estilo de vida y salud: Un problema educativo Educere. Recuperado de: http://www.redalyc.org/pdf/356/Resumenes/Resumen_35617102005_1.pdf

  18. Huertas-Vázquez A., Plaisier, C., Weissglas-Volkov, D., Sinsheimer, J., Canizales-Quinteros, S. (2008). TCF7L2 is Associated with High Serum Triacylglycerol and Differentially Expressed in Adipose Tissue in Families with Familial Combined Hyperlipidaemia. Diabetologia 51(1), 62-9. Recuperado de: https://www.ncbi.nlm.nih.gov/pubmed/17972059

  19. International Diabetes Federation. (2006). The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Promoting Diabetes Care, Prevention and a Cure Worldwide. Recuperado de: https://www.idf.org/webdata/docs/MetS_def_update2006.pdf

  20. Kunstmann, S. (2008). Síndrome Metabólico y riesgo cardiovascular. Rev. Med. Clin. Las Condes, 19(1),40-6.

  21. Kunstmann F. y Gainza, D. (2010). Estrategias de prevención y detección de riesgo cardiovascular. Rev. Med. Clin. Las Condes, 21 (5) 697-704. Recuperado de: http://www.sciencedirect.com/science/ article/pii/S0716864010705903

  22. Lepor NE., Vogel, RE. (2001) Summary of the Third Report of the National Cholesterol Education Program Adult Treatment Panel III. Rev. Cardiovasc. Med. 2(3), 160-5. Recuperado de: https://www. ncbi.nlm.nih.gov/pubmed/12439378

  23. Leung, WYS., So, W. Y., Tong, P.C.Y. et al. (2005)… The Effects of a Pharmacist Diabetologist Managed Diabetic Nephropathy Clinic Reduces Risk of End Stage of Renal Disease. Am. J. Med. 118: 1414. Recuperado de: http://www.sciencedirect.com/science/article/pii/S0002934305006613

  24. Lizarzaburu Robles, JC. (2013). Síndrome metabólico: concepto y aplicación práctica. An. Fac. med. 74(4), 315-320. Recuperado de: http://www.scielo.org.pe/scielo.php?pid=S1025- 55832013000400009&script=sci_arttext

  25. Lobos et al. (2008). European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC Spanish Adaptation. Rev. Esp. Salud Pública, 82 (6), 581-616. Recuperado de: https:// ac.els-cdn.com/S0212656709002546/1-s2.0-S0212656709002546-main.pdf?_tid=a1adffec-c425- 11e7-9ae0-00000aacb361&acdnat=1510105336_68795cca3ec8ae63e2b036f015274a18

  26. Lopez-Siguero, JP. (2016). Riesgos metabólicos del consumo excesivo de bebidas con azúcares refinados. Nutr. Hosp. 25; 33(2),199-200. Recuperado de: http://scielo.isciii.es/scielo.php?script=sci_ arttext&pid=S0212-16112016000200001

  27. Mottillo, S., Filion, KB., Genest, J., Joseph, L., Pilote, L., Poirier, P., et al. (2010). The Metabolic Syndrome and Cardiovascular Risk. A Systematic Review and Meta-Analysis. J. Am. Coll. Cardiol. 56, 1113-32. Recuperado de: https://ac.els-cdn.com/S0735109710026380/1-s2.0-S0735109710026380-main. pdf?_tid=206ccd72-c426-11e7-856c-00000aacb35d&acdnat=1510105549_78e295471d6d29a03c7 459931ce781a5

  28. National Cholesterol Education Panel Adult Treatment Panel III. Expert Panel (2002).Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Recuperado de: http:// circ.ahajournals.org/content/106/25/3143.full.pdf

  29. Olijhoek, JK., Van der Graaf, Y., Banga, JD., Algra, A., Rabelink, TJ., Visseren, FLJ.(2004).The Metabolic Syndrome is Associated with Advanced Vascular Damage in Patients with Coronary Heart Disease, Stroke, Peripheral Arterial Disease or Abdominal Aortic Aneurysm. Fur. Heart J.25(4), 342-8. Recuperado de: https://academic.oup.com/eurheartj/article/25/4/342/523828

  30. Organización de las Naciones Unidas. (2013). Indicadores de los objetivos de desarrollo del milenio (ODM). Recuperado de: http://millenniumindicators.un.org/unsd/mdg/Home.aspx

  31. Organización de las Naciones Unidas. (2011). Proyecto de resolución presentado por el Presidente de la Asamblea General. Declaración Política de la Reunión de Alto Nivel de la Asamblea General sobre la Prevención y el Control de las Enfermedades no Transmisibles. Recuperado de: http://www.un.org/ es/ga/ncdmeeting2011/

  32. Organización Mundial de la Salud. (2013). Report Global Strategy on Diet, Physiscal Activity and Health. Global strategy on diet, physical activity and health Diet and Physical activity: A public Health priority. Recuperado de: http://www.who.int/dietphysicalactivity/en

  33. Organización Panamericana de la Salud. (1986). Carta de Ottawa para la promoción de la salud. Primera Conferencia Internacional sobre la promoción de la salud. Recuperado de: http://www1. paho.org/Spanish/hpp/ottawacharterSp.pdf

  34. Organización Mundial de la Salud. (2009). Subsanar las desigualdades en una generación. Informe Final. Recuperado de: http://apps.who.int/iris/bitstream/10665/44084/1/9789243563701_spa. pdf

  35. Organización Mundial de la Salud. (2013). The 8th Global Conference on Health Promotion. The Helsinki Statment in Health in All Policies. Recuperado de: http://www.promocion.salud.gob.mx/ dgps/descargas1/promocion/8GCHPHelsinki_Statement.pdf

  36. Parra, EJ. Cameron, E., Simmonds, L., Valladares, A., Mckeigue, P., Shiver, M., Wacher, N., Kumate, J., Kittles, R., Cruz, M. (2007) Association of TFC7L2 Polymorphisms with Type 2 Diabetes in Mexico city. Clinical Genetics, 71(4), 3593-66. Recuperado de: http://onlinelibrary.wiley.com/doi/10.1111/ j.1399-0004.2007.00780.x/epdf ?r3_referer=wol&tracking_action=preview_click&show_ checkout=1&purchase_referrer=onlinelibrary.wiley.com&purchase_site_license=LICENSE_DENIED

  37. Pilgaard, K., Jensen, CB., Schou, JH. et al. (2009). The T Allele of rs7903146 TCF7L2 is Associated with Impaired Insulinotropic Action of Incretin Hormones, Reduced 24h Profiles of Plasma Insulin and Glucagon, and Increased Hepatic Glucose Production in Young Healthy Men. Diabetologia. 2016(52). Recuperado de:https://link.springer.com/article/10.1007/s00125-009-1307-x

  38. Pollak, F., Araya, V., Lanas, A., Espunar, J. et al. (2015). II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre Resistencia a la Insulina. Rev. Med. Chile, 143, 637-650. Recuperado de: http://www.scielo.cl/scielo.php?pid=S0034-98872015000500012&script=sci_arttext

  39. Reaven, GM. (1988). Role of Insulin Resistance in Human Disease. Diabetes Journals, 37(12),1595- 1607 Recuperado de: http://diabetes.diabetesjournals.org/content/37/12/1595

  40. Rivera Dommarco, J., Hernández Avila, M., Aguilar Salinas, CA., Vadillo Ortega, F., Murayama Rendón, C. (2013). Obesidad en México: recomendaciones para una Política de Estado. 1ra. Ed. Ciudad de México, México: UNAM.

  41. Roberts, CK., Barnard, RJ. (2005). Effects of Exercise and Diet on Chronic Disease. J. Appl. Physiol., 98, 3-30. Recuperado de: http://jap.physiology.org/content/98/1/3.full.pdf+html

  42. Rodríguez Porto, AL., Sánchez León, M, y Martínez Valdés, L. (2002). Síndrome Metabólico. Rev. Cub. End. 13 (3). Recuperado de: http://scielo.sld.cu/scielo.php?script=sci_ arttext&pid=S1561-29532002000300008

  43. Ruano Nieto, CI., Melo Pérez, JD., Mogrovejo Freire, L., De Paula Morales, KR., Espinoza Romero, CV. (2015). Prevalencia de síndrome metabólico y factores de riesgo asociados en jóvenes universitarios ecuatorianos. Nutr Hosp 1; 31(4), 1574-81. Recuperado de: http://www.redalyc.org/ html/3092/309238513016/

  44. Sarafidis, PA., Nilsson, PM. (2006). The Metabolic Syndrome: a Glance at its History. Journal of Hypertension, 24(4), 621-6. Recuperado de: http://journals.lww.com/jhypertension/ Abstract/2006/04000/The_metabolic_syndrome__a_glance_at_its_history.3.aspx

  45. Schnell, M., Domínguez, Z., Carrera, C. (2007). Aspectos genéticos, clínicos y fisiopatológicos del Síndrome Metabólico. An. Venezuel. Nutric., 20(2), 92-8. Recuperado de: https://www. researchgate.net/profile/Zury_Dominguez/publication/236020230_Aspectos_geneticos_clinicos_y_ fisiopatologicos_del_Sindrome_Metabolico/links/00463515ce33fa34c1000000/Aspectos-geneticosclinicos- y-fisiopatologicos-del-Sindrome-Metabolico.pdf

  46. Soca, PE. (2009). El Síndrome Metabólico: un alto riesgo para individuos sedentarios. Acimed., 20(2), 1-8, Recuperado de: http://scielo.sld.cu/scielo.php?script=sci_ arttext&pid=S1024-94352009000800007

  47. Texas Heart Institute, (2012). Síndrome Metabólico. Recuperado de: http://www.texasheart. org/HIC/Topics_Esp/Cond/metabolic_sp.cfm

  48. UNESCO. (2001).Informe del Comité Regional Intergubernamental del Proyecto Principal De Educación en América Latina y El Caribe, Recuperado de: http://unesdoc.unesco.org/ images/0012/001235/123546s.pdf

  49. União Internacional de Promoção da Saúde e da Educação. (2016). Carta de Curitiba sobre Promoção da Saúde e Equidade. Recuperado de: https://www.abrasco.org.br/site/noticias/saudeda- populacao/carta-de-curitiba-sobre-promocao-da-saude-e-equidade/19821/

  50. Van Gaal, LF., Mersten, IL., De Block, CE. (2006). Mechanism Linking Obesity with Cardiovascular Disease. Nature, 14 (7), 875-880.Recuperado de: http://semmelweis.hu/biokemia/files/2014/09/ EN_con_INS14_Obesity-and-heart-disease-2006.pdf

  51. Vicario A., Cerezo GH., Zilberman, Del Sueldo, M. (2011). Prevalencia del síndrome metabólico en la consulta cardiológica y utilidad de la percepción médica como herramienta diagnóstica. Estudio CARISMA (Caracterización y Análisis del Riesgo en Individuos con Síndrome Metabólico en la Argentina). Rev. Fed. Arg. Cardiol. 40(2),152-7. Recuperado de: http://www.fac.org.ar/1/ revista/11v40n2/art_orig/arorig03/vicario.pdf

  52. Villalobos Molina, R., Wall Medrano, A., Rodríguez Tadeo, A. el al (2015). Hipertriglyceridemic- Waist (HTGW) Phenotype in university students from two regions of México. Acta Médica Mediterránea (31),173. Recuperado de: https://www.researchgate.net/profile/Rene_Urquidez- Romero/publication/272744867_Hypertriglyceridemic-Waist_HTGW_Phenotype_in_University_ Students_from_two_Regions_of_Mexico/links/54ecd4af0cf27fbfd771a49a/Hypertriglyceridemic- Waist-HTGW-Phenotype-in-University-Students-from-two-Regions-of-Mexico.pdf

  53. Vindas, G. (2008). Síndrome Metabólico. Rev. Med. Costa Rica y Centro América. LXIII(575), 77-9.

  54. Zalesin, KC., Franklin BA., Miller, WM. et al. (2008). Impact of Obesity on Cardiovascular Disease. Endocrinol. Metab. Clin. N. Am.(37), 663-684. Recuperado de: http://www.sciencedirect.com/ science/article/pii/S0889852908000364

  55. Zimmet, P., Alberti, G., Shaw, J. (2005). A new IDF Worldwide Definition of the Metabolic Syndrome: the Rationale and the Results. Diabetes Voice, 50(3), 31-3. Recuperado de: https://www.ncbi.nlm.nih.




2020     |     www.medigraphic.com